An Act To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. FDA Reauthorization Act of 2017. H.R. 2430. 115th
Cong., 1st
sess., Placed on Calendar Senate July 17, 2017. https://www.govinfo.gov/app/details/BILLS-115hr2430pcs.
APA
Congress, Senate (2017, July 17). FDA Reauthorization Act of 2017 (H.R. 2430 (PCS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-115hr2430pcs.
MLA
United States, Congress, Senate. FDA Reauthorization Act of 2017. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-115hr2430pcs. 115th Congress, H.R. 2430, Placed on Calendar Senate 17 Jul. 2017.
Bluebook
H.R.2430 - 115th Congress (2017-2018): FDA Reauthorization Act of 2017, H.R.2430, 115th Cong. (2017), https://www.govinfo.gov/app/details/BILLS-115hr2430pcs.
